Table 1 Summary of the cohort clinical information and BRAF/NF1 alterations
From: The tumour microenvironment of pilocytic astrocytoma evolves over time via enrichment for microglia
Cohort | Age at diagnosis (Months) | Sample interval (Years) | BRAF/NF1 alterations |
|---|---|---|---|
All (n = 15) | 69.3 (10–150) | 2.73 (0.5-8) | KIAA1549::BRAF (n = 9) |
BRAF V600E (n = 1) | |||
NF1 deletion (n = 1) | |||
Male (n = 9) | 72.9 (11–150) | 2.8 (0.5-4) | KIAA1549::BRAF (n = 4) |
BRAF V600E (n = 1) | |||
NF1 deletion (n = 1) | |||
Female (n = 6) | 63.8 (10–146) | 2.5 (0.5-8) | KIAA1549::BRAF (n = 5) |